Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment

Latent autoimmune diabetes of the adult: current knowledge and uncertainty

(2015) E. Laugesen et al.   DIABETIC MEDICINE

Obesity, Islet Cell Autoimmunity, and Cardiovascular Risk Factors in Youth at Onset of Type 1 Autoimmune Diabetes

(2015) Maribel Cedillo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?

(2014) Philip Home et al.   DIABETES CARE

LADA and CARDS: A Prospective Study of Clinical Outcome in Established Adult-Onset Autoimmune Diabetes

(2014) Mohammed Iqbal Hawa et al.   DIABETES CARE

Latent Autoimmune Diabetes in Adults With Low-Titer GAD Antibodies: Similar Disease Progression With Type 2 Diabetes

(2014) Lingjiao Liu et al.   DIABETES CARE

β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment

(2014) Philippe A. Halban et al.   DIABETES CARE

Similar weight-adjusted insulin secretion and insulin sensitivity in short-duration late autoimmune diabetes of adulthood (LADA) and Type 2 diabetes: Action LADA 8

(2014) C. B. Juhl et al.   DIABETIC MEDICINE

Cord blood insulinoma-associated protein 2 autoantibodies are associated with increased risk of type 1 diabetes in the population-based Diabetes Prediction in Skåne study

(2014) Markus Lundgren et al.   DIABETOLOGIA

Dipeptidyl Peptidase 4 Inhibitor Sitagliptin Maintains β-Cell Function in Patients With Recent-Onset Latent Autoimmune Diabetes in Adults: One Year Prospective Study

(2014) Yunjuan Zhao et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease

(2014) Sarah E Flanagan et al.   NATURE GENETICS

Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis

(2014) Kaixin Zhou et al.   Lancet Diabetes & Endocrinology

Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes

(2013) John B. Buse et al.   ANNALS OF INTERNAL MEDICINE

Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial

(2013) J. M. Lachin et al.   DIABETES

Personalized Management of Hyperglycemia in Type 2 Diabetes: Reflections from a Diabetes Care Editors' Expert Forum

(2013) I. Raz et al.   DIABETES CARE

The latest pharmacotherapy options for type 1 diabetes

(2013) Johnny Ludvigsson   EXPERT OPINION ON PHARMACOTHERAPY

Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future

(2013) Steven E Kahn et al.   LANCET

The many faces of diabetes: a disease with increasing heterogeneity

(2013) Tiinamaija Tuomi et al.   LANCET

Type 1 diabetes

(2013) Mark A Atkinson et al.   LANCET

Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study

(2013) Kristine Færch et al.   Lancet Diabetes & Endocrinology

Frequency, Immunogenetics, and Clinical Characteristics of Latent Autoimmune Diabetes in China (LADA China Study): A Nationwide, Multicenter, Clinic-Based Cross-Sectional Study

(2012) Z. Zhou et al.   DIABETES

Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype: Action LADA 7

(2012) M. I. Hawa et al.   DIABETES CARE

Systematic Assessment of Etiology in Adults With a Clinical Diagnosis of Young-Onset Type 2 Diabetes Is a Successful Strategy for Identifying Maturity-Onset Diabetes of the Young

(2012) G. Thanabalasingham et al.   DIABETES CARE

Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study

(2012) D. Dabelea et al.   DIABETOLOGIA

Worse glycaemic control in LADA patients than in those with type 2 diabetes, despite a longer time on insulin therapy

(2012) C. D. Andersen et al.   DIABETOLOGIA

Levels of C-peptide, body mass index and age, and their usefulness in classification of diabetes in relation to autoimmunity, in adults with newly diagnosed diabetes in Kronoberg, Sweden

(2012) Maria Thunander et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

GADA Titer-Related Risk for Organ-Specific Autoimmunity in LADA Subjects Subdivided according to Gender (NIRAD Study 6)

(2012) Simona Zampetti et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes

(2012)   NATURE GENETICS

Genetic Analysis of Adult-Onset Autoimmune Diabetes

(2011) J. M. M. Howson et al.   DIABETES

Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4

(2011) M. N. Pham et al.   DIABETOLOGIA

Pharmacogenetics in type 2 diabetes: potential implications for clinical practice

(2011) Chunmei Huang et al.   Genome Medicine

Identification of Autoantibody-Negative Autoimmune Type 2 Diabetic Patients

(2010) B. M. Brooks-Worrell et al.   DIABETES CARE

Association of T-cell reactivity with β-cell function in recent onset type 1 diabetes patients

(2009) Christian Pfleger et al.   JOURNAL OF AUTOIMMUNITY

Improved T cell assay for identification of type 1 diabetes patients

(2009) Barbara Brooks-Worrell et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Distinct Monocyte Gene-Expression Profiles in Autoimmune Diabetes

(2008) R. C. Padmos et al.   DIABETES

Genetic Similarities Between Latent Autoimmune Diabetes in Adults, Type 1 Diabetes, and Type 2 Diabetes

(2008) C. Cervin et al.   DIABETES

Metabolic Syndrome and Autoimmune Diabetes: Action LADA 3

(2008) M. I. Hawa et al.   DIABETES CARE